Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Person writing with pen

What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus.

Evers AWM. et al, (2020), Psychother Psychosom, 1 - 8

Opioids for breathlessness: psychological and neural factors influencing response variability.

Abdallah SJ. et al, (2019), Eur Respir J, 54

Inclusion of patient functional neuroimaging metrics in early analgesic drug development. Reply to Br J Anaesth 2018; 121: 969-71.

Wanigasekera V. et al, (2019), Br J Anaesth

Central Sensitization in Knee Osteoarthritis: Relating Presurgical Brainstem Neuroimaging and PainDETECT-Based Patient Stratification to Arthroplasty Outcome.

Soni A. et al, (2019), Arthritis Rheumatol, 71, 550 - 560

Sertraline or placebo in chronic breathlessness? Lessons from placebo research.

Pattinson K. and Wanigasekera V., (2019), Eur Respir J, 53

Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging.

Wanigasekera V. et al, (2018), Br J Anaesth, 120, 299 - 307

Opioids decrease the unpleasantness of dyspnoea via actions in the medial prefrontal cortex

Hayen A. et al, (2017), BIOLOGICAL PSYCHOLOGY, 129, 375 - 376

Opioid suppression of conditioned anticipatory brain responses to breathlessness.

Hayen A. et al, (2017), Neuroimage, 150, 383 - 394

OUP accepted manuscript

(2017), British Journal Of Anaesthesia

NEUROIMAGING EVIDENCE OF CENTRAL SENSITIZATION IN PATIENTS WITH KNEE OSTEOARTHRITIS

Soni A. et al, (2016), OSTEOARTHRITIS AND CARTILAGE, 24, S443 - S443

Disambiguating Pharmacodynamic Efficacy from Behavior with Neuroimaging: Implications for Analgesic Drug Development.

Wanigasekera V. et al, (2016), Anesthesiology, 124, 159 - 168

Learning to identify CNS drug action and efficacy using multistudy fMRI data.

Duff EP. et al, (2015), Sci Transl Med, 7

Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain

Lee MC. et al, (2014), Neuropharmacology, 84, 123 - 130

Amygdala activity contributes to the dissociative effect of cannabis on pain perception.

Lee MC. et al, (2013), Pain, 154, 124 - 134

Baseline reward circuitry activity and trait reward responsiveness predict expression of opioid analgesia in healthy subjects.

Wanigasekera V. et al, (2012), Proc Natl Acad Sci U S A, 109, 17705 - 17710

Stimulus site and modality dependence of functional activity within the human spinal cord.

Brooks JCW. et al, (2012), J Neurosci, 32, 6231 - 6239

Imaging opioid analgesia in the human brain

Lee MC. et al, (2012), Trends in Anaesthesia and Critical Care

Neural correlates of an injury-free model of central sensitization induced by opioid withdrawal in humans.

Wanigasekera V. et al, (2011), J Neurosci, 31, 2835 - 2842

The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil.

Bingel U. et al, (2011), Sci Transl Med, 3

Effects of propofol and thiopentone, and benzodiazepine premedication on heart rate variability measured by spectral analysis.

Howell SJ. et al, (1995), Br J Anaesth, 74, 168 - 173

Include forthcoming?